About Cannara Biotech
Cannara Biotech is a company based in Montreal (Canada) founded in 2018 by Zohar Krivorot.. Cannara Biotech has raised $17.66 million across 4 funding rounds from investors including Canadian Imperial Bank of Commerce and FSD Pharma. The company has 363 employees as of August 31, 2024. Cannara Biotech has completed 1 acquisition, including Shop CBD. Cannara Biotech offers products and services including Dried Flowers, Pre-Rolls, and Cannabis Oils. Cannara Biotech operates in a competitive market with competitors including Canopy Growth, Organigram, C21 Investments, PharmaCielo and Aphria, among others.
- Headquarter Montreal, Canada
- Employees 363 as on 31 Aug, 2024
- Founders Zohar Krivorot
- Stage Public
-
Sectors
HealthcareAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cannara Biotech, Inc.
-
Annual Revenue
$56.82 M (USD)42.77as on Aug 31, 2024
-
Net Profit
$4.48 M (USD)-7.3as on Aug 31, 2024
-
EBITDA
$-8.03 M (USD)-160.19as on Aug 31, 2024
-
Total Equity Funding
$17.66 M (USD)
in 4 rounds
-
Latest Funding Round
$5 M (USD), Post-IPO
Jul 09, 2021
-
Investors
Canadian Imperial Bank of Commerce
& 1 more
-
Employee Count
363
as on Aug 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cannara Biotech
Cannara Biotech is a publicly listed company on the TSXV with ticker symbol LOVE in Canada, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cannara Biotech
Cannara Biotech offers a comprehensive portfolio of products and services, including Dried Flowers, Pre-Rolls, and Cannabis Oils. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Premium cultivated cannabis flowers for recreational and medical use.
Convenient pre-rolled cannabis for easy consumption.
Extracted oils from cannabis for versatile applications.
Unlock access to complete
Funding Insights of Cannara Biotech
Cannara Biotech has successfully raised a total of $17.66M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $5.0M
-
First Round
First Round
(24 Jul 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Cannara Biotech | Valuation |
investors |
|
| Oct, 2019 | Amount | Debt – Conventional - Cannara Biotech | Valuation |
investors |
|
| Jul, 2019 | Amount | Post-IPO - Cannara Biotech | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cannara Biotech
Cannara Biotech has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce and FSD Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Commercial banking services are provided to individuals and businesses.
|
Founded Year | Domain | Location | |
|
Cannabis company engaged in cultivation, processing, and manufacturing related activities
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cannara Biotech
Cannara Biotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Shop CBD. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Personal care products are retailed by Shop CBD in Canada.
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Cannara Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cannara Biotech Comparisons
Competitors of Cannara Biotech
Cannara Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Canopy Growth, Organigram, C21 Investments, PharmaCielo and Aphria, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cannabis products are provided to support consumer wellness and health.
|
|
| domain | founded_year | HQ Location |
Provider of cannabis products, brands, and international business development investments
|
|
| domain | founded_year | HQ Location |
Cannabis and hemp-derived products are cultivated, processed, and supplied.
|
|
| domain | founded_year | HQ Location |
Medicinal cannabis oil and products are produced in Colombia.
|
|
| domain | founded_year | HQ Location |
Cannabis-derived nutritional and wellness products are provided by Aphria.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cannara Biotech
Frequently Asked Questions about Cannara Biotech
When was Cannara Biotech founded?
Cannara Biotech was founded in 2018.
Where is Cannara Biotech located?
Cannara Biotech is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Who is the current CEO of Cannara Biotech?
Zohar Krivorot is the current CEO of Cannara Biotech. They have also founded this company.
Is Cannara Biotech a funded company?
Cannara Biotech is a funded company, having raised a total of $17.66M across 4 funding rounds to date. The company's 1st funding round was a Post-IPO of $2.16M, raised on Jul 24, 2018.
How many employees does Cannara Biotech have?
As of Aug 31, 2024, the latest employee count at Cannara Biotech is 363.
What is the annual revenue of Cannara Biotech?
Annual revenue of Cannara Biotech is $56.82M as on Aug 31, 2024.
What does Cannara Biotech do?
Cannara Biotech was established in 2018 in Montreal, Canada, as a facility focused on the medicinal cannabis sector. Organic cannabis is cultivated and infused with medicinal herbs and flowers. Cannabis oil is also extracted through specialized processes. Operations are centered on production for medicinal applications, with the company serving the Canadian market from its primary location.
Who are the top competitors of Cannara Biotech?
Cannara Biotech's top competitors include Canopy Growth, Organigram and Aphria.
What products or services does Cannara Biotech offer?
Cannara Biotech offers Dried Flowers, Pre-Rolls, and Cannabis Oils.
Is Cannara Biotech publicly traded?
Yes, Cannara Biotech is publicly traded on TSXV under the ticker symbol LOVE.
How many acquisitions has Cannara Biotech made?
Cannara Biotech has made 1 acquisition, including Shop CBD.
Who are Cannara Biotech's investors?
Cannara Biotech has 2 investors. Key investors include Canadian Imperial Bank of Commerce, and FSD Pharma.
What is Cannara Biotech's ticker symbol?
The ticker symbol of Cannara Biotech is LOVE on TSXV.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.